*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Stocks in Europe finished the session at their best level in over a month ahead of the start of the second quarter earnings season, even as the single currency continued to bound higher.
Investors will be closely watching Tuesday morning's data release on UK gross domestic product, following a 20. 4% plunge that pushed the country's economic output down to levels last seen in 2002.
Alphabet said on Monday that it will spend around $10bn on equity investments and tie-ups in the up-and-coming Indian market over the next five to seven years.
London stocks closed well above the waterline on Monday, despite ongoing concerns about the pandemic, with miners pacing the gains as copper prices rallied and as hopes of a Covid-19 vaccine lifted sentiment.
Energean revealed on Monday that chief executive Matthaios Rigas had acquired 10,000 ordinary shares in the FTSE 250-listed exploration and production company.
JPMorgan Cazenove upgraded its stance on shares of Ryanair on Monday, arguing that the budget airline is a long-term winner in European aviation with its "fortress balance sheet" and ultra-low costs.
Monitoring and security company Remote Monitored Systems announced the successful completion of a placing to raise £0. 27m on Monday, to support the continuing growth of GyroMetric and Cloudveil, and to provide working capital.
Pharmaceutical services company Clinigen Group announced on Monday that the US Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted orphan drug designation for ‘aldesleukin’, in the treatment of amyotrophic lateral sclerosis (ALS).
Equity strategists at Morgan Stanley sounded a positive note on so-called 'value' stocks, arguing that the economic cycle was shifting into a 'recovery regime' - but there was catch.
Canada and Australia-focussed mineral exploration company Panther Metals announced the enlargement of the Big Bear Project area on Monday, following an airborne geophysics survey.
Defence technology company Qinetiq said on Monday that it has entered "the next phase of growth in the US" after agreeing to operate all of the US defence and security operations for the US Defense Counterintelligence & Security Agency (DCSA) under a new special security agreement (SSA).
G4S is planning to cut 1,150 jobs at its cash business in a move that takes Britain closer to a cashless society, according to one of the UK's biggest unions.
Wall Street stocks opened sharply higher at the bell on Monday as investors appeared to ignore another record spike in new Covid-19 cases in Florida at the weekend.
Libya is set to resume crude oil exports in the wake of successful talks between the country's two warring factions following talks led by the United Nations and the United States.
The Governor of the Bank of England has told school pupils the economy is starting to recover but that the central bank was extremely worried about unemployment.
Research into potential Covid-19 vaccines being developed by Pfizer and BioNTech has been granted so-called Fast Track designation by the US Food and Drug Administration, sending shares in both drug firms higher.
